For example, it has been noted that elevated levels of serum IL-33 and IL-33 receptor genetic polymorphism are evident in patients with multiple sclerosis, suggesting a significant role of this cytokine in the pathogenesis of autoimmune disorders [18]. This evidence concerns the gene IL33 and multiple sclerosis.